100 days with John Crowley: Behind BIO’s new structure & vision
WEBJun 25, 2024 · With only a little more than 100 days at the helm, BIO CEO John Crowley has already implemented a restructure and taken a stance on U.S. biosecurity.
BIO CEO John Crowley interview: China, vaccines, and Trump - STAT
WEBJul 18, 2024 · W ASHINGTON — BIO’s new CEO John Crowley is making changes. He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial social issues.
BIO names John F. Crowley as new President & CEO - Bio.News
WEBDec 5, 2023 · The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the biotech industry, to fill the role of the organization’s new President & CEO.
He Designed Drugs to Save His Children. Now He’s Working to …
WEBDec 5, 2023 · Nearly a quarter-century after plunging into biotech to find drugs to save Megan and her younger brother, Patrick, from a rare and deadly genetic disease, Crowley feared the battle had suddenly...
John Crowley (businessman) - Wikipedia
WEBJohn Francis Crowley (born April 7, 1967) is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. [1] He served as the chairman and CEO of Amicus Therapeutics.
BIO selects John Crowley as new CEO - STAT
WEBDec 5, 2023 · W ASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday....
Meet John Crowley: Biotech Visionary, Devoted Father, and New …
WEBJun 17, 2024 · As the newly appointed President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy group, Crowley brings a unique blend of personal passion and professional expertise to his role.
Industry Leader and Globally Recognized Patient Advocate John F …
WEBDec 5, 2023 · Biotech entrepreneur, company founder, tireless patient advocate, and U.S. Navy combat veteran will guide the life science industry in its mission to feed, fuel and heal the world.
BIO names longtime Amicus head John Crowley as new CEO
WEBDec 5, 2023 · The Biotech Innovation Organization on Tuesday named Amicus Therapeutics co-founder and longtime leader John Crowley as its new CEO, taking over a spot interim chief Rachel King has held for the past 14 months.
Amicus Leader, BIO Board Member John Crowley Named Trade ... - MedCity News
WEBDec 5, 2023 · John Crowley, the longtime leader of rare disease drug developer Amicus Therapeutics and a board member of the Biotechnology Innovation Organization, will become the trade organization’s new...